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Abstract. The questions ‘What constitutes a good health care decision?’, and, by 
extension, ‘What constitutes good healthcare decision support?’ continue to be 
asked. The most developed answers focus largely, often exclusively, on the quality 
of the ‘deliberation’ component as the determinant of the quality of the decision or 
decision aid. We argue that these answers and resulting aids reflect the preferences 
of healthcare professionals and aid developers and that these preferences are closely 
aligned with their interests. Some interests are material, but many professional, 
institutional, intellectual, methodological, and ethical. Successful promotion of a 
particular preference-sensitive, interest-conflicted decision aid does not change its 
ontological nature. Conflicts of interest are therefore universal and of concern only 
when this ontology is denied and if aids based on alternative interest-based 
preferences, such as technologies involving numerical analytic calculation, are 
subjected to discrimination. 
Keywords. Decision quality, decision aid, evaluation, deliberation, three-talk-
model, preference-sensitive, conflict of interest 
Introduction 
Can decisions be judged good or not, and, if so, how might this goodness be evaluated? 
It is hard to envisage a more important question in health and healthcare. It remains so 
whether or not we substitute ‘the best decision’, or ‘satisfactory decision’, for ‘a good 
decision’, or simply ask how a decision can be evaluated. In all cases what is at issue is 
the quality of a decision. By extension, the same questions apply to evaluating the quality 
of decision support, such as that offered by technologies in the form of ‘decision aids’, 
some computer-based and interactive online, some not. 
The questions remain the same whether they are asked at the individual or group 
level, despite the other vast differences that exist in these two contexts. But we confine 
ourselves here to the individual context, as personified in the clinical decision. In their 
2010 reflections on these questions, Elwyn and Miron-Shatz criticized previous answers 
and made a proposal that became the basis of considerable subsequent elaboration and 
development [1, 2, 3, 4, 5]. The initial proposal assumed that a clear three stage sequence 
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exists: a pre-decisional deliberation process, an act of decision determination, and post-
decisional outcomes. Previous proposals were criticized, for failing to distinguish 
between the pre-decisional process of deliberation and the subsequent act of decision 
determination. This act was defined as ‘choosing an option’. 
Surprisingly, and contrary to the expectation set up by the stressing of this distinction, 
their proposal involved evaluating only the first stage, the pre-decisional deliberative 
process. They propose 
“… a framework for evaluating the deliberation phase which we hypothesize, if done 
well, may lead to a good decision determination … Evaluating the deliberation process, 
we propose, should comprise of a subjective sufficiency of knowledge, as well as 
emotional processing and affective forecasting of the alternatives. This should form the 
basis for a good act of determination.” [1] (p140). 
The proposal leaves the act of determination unconsidered - and the question ‘Can 
an act of determination be judged good or not, and if so, how might this goodness be 
evaluated?’ unaddressed. This question is not raised in follow-up research either, and 
work has continued to focus exclusively on establishing the criteria for a good 
deliberative process. Despite the cautious wording in the above quotations (‘may lead 
to’, ‘form the basis for’) the quality of the act of determination is effectively left equated 
with the quality of the preceding process of deliberation. 
A revised model was introduced in 2017 with the specific aim of improving the 
quality of shared decision making. 
“A new three-talk model of shared decision making is proposed, based on ‘team 
talk’, ‘option talk’, and ‘decision talk’, to depict a process of collaboration and 
deliberation. Team talk places emphasis on the need to provide support to patients when 
they are made aware of choices, and to elicit their goals as a means of guiding decision 
making processes. Option talk refers to the task of comparing alternatives, using risk 
communication principles [in discussing harms and benefits]. Decision talk refers to the 
task of arriving at decisions that reflect the informed preferences of patients. The 
overarching goal [is] a model that can act as … a primer, a reminder, and a guide to 
accomplishing shared decision making. Shared decision making is sometimes supported 
by patient decision aids, which often include risk communication formats. These would 
fit naturally in the ‘option talk’ step.” [3] (Abstract, Appendix Table A). 
Unfortunately, it is left unclear as to how it is possible for the ‘option talk’ to 
‘compare alternatives’ in a personalized way without introducing the preferences of this 
patient in this second phase. Nor how this non-personalized ‘comparative talk’ can 
transform the preferences of this patient from ‘uninformed’ ones to the ‘informed’ ones 
in the ‘decision talk’ and thence embedded in the decision. Aids to support decision 
making are mentioned, but they focus on information provision, leaving the crucial task 
of integrating evidence and preferences unaddressed. So, while the last phase - ‘decision 
talk’ - is now more complex than a simple ‘act of determination’, it is still the case that 
‘choice between options’ just happens. A mind is made up. 
1. Preferences and Interests 
The main objective of this paper is not to criticize the Elwyn models. It is to make clear 
that, in pointing out what we see as weaknesses in them, we are reflecting our preferences. 
The models are not rejected as possible constructions of a decision support and making 
process, or as possible bases on which the quality of these processes can be evaluated. 
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But the implicit equation of the quality of the act of determination with the quality of the 
preceding process of deliberation is far removed from our preferences. We regard 
equating ‘a good deliberative process’ with ‘a good decision’ - and ‘good support for a 
deliberative process’ with ‘good decision support’ - as reflecting particular ‘tastes’ in the 
Bourdieusian sense [6]. While this equating may be a widespread preference, it is not 
ours and its popularity does not affect its ontology. One important consequence of our 
very different preferences is that technological support in the form of analytical decision 
aids becomes virtually a necessity to achieve higher quality, preference-sensitive 
decisions. 
Quality is a formative construct. In contrast to a reflective construct (such as an 
‘inflamed appendix’), it does not exist until it is formed, i.e. defined and, in most cases, 
measured [7]. All serious evaluative measures in healthcare - including evaluations of 
any product, process or activity - are multi-criterial. They take the form of indexes 
produced by weighting a selected set of criterion scales. Using equal weights for the item 
scales in an instrument is still assigning weights. Note also that the output from a ‘profile’ 
instrument - set of unaggregated criterion scales - does not constitute a measure of quality. 
The selection of the criteria for an index, and the weights assigned to them, reflect 
underlying value judgments, so that all evaluation measures, including decision quality, 
are both preference-based and preference-sensitive. 
These preferences - and the concepts and measures into which they are built - are 
reflections of ‘taken-for-granted’ assumptions within the field’s doxa. Many of these 
assumptions are aligned with interests of various sorts. Some may be directly financial, 
but these can be less important than other material and non-material interests, such as the 
advancement of a professional career or institutional reputation, or implementing 
particular political, ideological, methodological or ethical positions (e.g. deontological 
or consequentialist). When the embodiment of interest-based preferences in quality 
measures and other evaluations is unconscious, the danger is that this will lead 
developers and users to reject (or accept) alternative measures, rather than 
acknowledging that they are based on different preferences and interests. 
It will make little sense to the reader if the existence of a decision aid based on our 
very different preferences and interests is not referenced. As has been already suggested, 
these preferences are for decision support based on numerical analytic calculation, as 
opposed to the verbal deliberative reasoning format of most current decision aids [8]. 
Crucially, these preferences involve the provision of an opinion on the decision, 
explicitly omitted by aids that can, nevertheless, meet the preference-sensitive 
International Patient Decision Aid Standards checklist [9]. Figure 1 provides an 
illustration of a generic Multi-Criteria Decision Analysis-Based Decision Support Tool 
(DST) for use in clinical and commissioning decisions [10]. It can be engaged with at 
https://ale.rsyd.dk (enter 1513 as survey ID). 
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Figure 1: Example of the GREST decision support tool [10] 
 
The nature and scope of ‘interests’ and ‘conflicts of interest’, is the subject of a BMJ 
‘head to head’ [11]. Saver [12] and Rodwin [13] represent the opposing positions. 
Saver makes the case for widening the legal definition and regulation of non-
financial interests to include those which create ‘misaligned incentives’ problems. And 
he notes the support for such expansion: ‘… the editors of PLoS Medicine note that 
professional affinities and rivalries…scientific or technological competition, religious 
beliefs, and political or ideological views are often the fuels for (academic) passions and 
for (research) careers…(and these) interests are perhaps even more potent than financial 
ones.’ [12] (p469). 
Rodwin wishes to limit conflicts of interest to those in the current law: “Redefining 
“conflicts of interest” to include any potential intellectual interests that conflict would 
make the concept a less practical tool. There is no effective way to eliminate most 
intellectual conflicts, which are widespread and an inherent part of life. Regulating these 
potential sources of bias using a conflict of interest framework would burden 
professionals and institutions for little benefit. On the other hand, financial conflicts of 
interest generally can be avoided or eliminated.” [11] (p2). 
Saver dismisses the suggestion that conflicts based on financial interests are much 
easier to distinguish, regulate and eliminate. It ignores the boundary-drawing problem in 
complex institutional arrangements where the pursuit of non-financial interests can bring 
financial benefits to both person - and their institution: ‘there is no free lunch, and all 
revenue accruing to anyone or any institution, from any company or governmental 
program, comes with strings attached.’ [12] (p471). 
Pointing out that ‘value-free evaluations’ is an oxymoron is not a recipe for nihilistic 
subjectivism. Preference-based measures of formative constructs are essential and 
unavoidable in healthcare. It is entirely normal and to be expected, even encouraged, that 
different preference-based measures of quality, including decision quality, be proposed, 
and support for their use sought. The danger lies in failing to acknowledge that that 
support can actually only be gained on the basis of mutually-shared interest-aligned 
preferences. There is an almost irresistible temptation to offer a formative measure as 
being akin to a ‘gold standard’ [9,14] when its defensible basis lies solely in the 
intersubjective support of those with similar (enough) preferences and (sufficiently) 
aligned interests. So, while the danger arises most obviously where there are financial 
interests underlying the preferences - making them literally value judgments - it also 
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exists, covertly, where the interests are only indirectly material and even if the developers 
are motivated by the purest of intentions (‘pro bono’). 
2. Discussion 
There is a distressingly large amount of work to be done. Two ‘‘crosstalk’’ sessions 
entitled ‘What is a ‘Good’ Medical Decision? Perspectives from Multiple Stakeholders.’ 
were held at the 2015 annual meetings of the Society of Behavioral Medicine Health 
Decision Making Special Interest Group and the Society for Medical Decision Making. 
According to the paper reporting on these sessions [15]. 
“… stakeholders and audience members agreed with the importance of both decision 
process and outcomes as criteria for a good decision. However, additional issues were 
identified as being central to answering the question, ‘what is a good decision?’ These 
issues included interpersonal factors, structural constraints, affective influences, and 
values clarification methods. These issues are highly relevant to patients’ experiences of 
both the process and outcomes of medical decision making; yet, each issue has gaps in 
scientific knowledge that limit the ability to develop a comprehensive definition of good 
decision making… In order to develop a comprehensive definition of decision quality 
and to advance the theory and practice of medical decision making, it is critical to 
consider novel factors that not only shape the process by which patients make medical 
decisions and the outcomes of those decisions, but also those factors that could serve as 
new metrics for identifying a good decision. This requires an acknowledgement and 
better scientific understanding of the real ways that patients make decisions.” [15] (pp55, 
64). 
However, the vast majority of healthcare decisions are multi-criterial, and therefore 
preference-sensitive, so ‘better scientific understanding’ can never answer the question. 
Seeking a preference-free definition of ‘a good medical decision’ is hunting the mythical 
Snark of Lewis Carroll [16]. As is trying to establish scientifically ‘the real way patients 
make decisions’. 
We focus on deliberation because it is taken-for-granted within the healthcare 
professional doxa that it is the only game in town as far as decision making and support 
is concerned. Regrettably, deliberation has never been subjected to comparative 
empirical evaluation in the way that the scientific orthodoxy would demand for any other 
process or product (e.g. drug, device) and as is routinely demanded of analytical decision 
aids. It is therefore particularly important to expose and counter those who benefit from 
presenting evaluations as truth claims, as is too often the case with so-called ‘scientific’ 
assessments. All clashes in evaluation - in the placing of value on - are clashes of 
preference. Even clinical trials are preference-sensitive and interest-biased, insofar as 
they claim to be evaluations of options [17]. 
3. Conclusion 
It is acceptable to define and measure the quality of a decision or decision support tool 
by the quality of its deliberation component, but this is subject to it being advanced as 
one of the many possible preference-based definitions and measures. Subject also to not 
dismissing rival ways of evaluating decision support technologies, except as a declared 
matter of preference. In two future papers [18,19] we show how the dominant normative 
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and empirical methods of decision aid evaluation reflect undeclared interest-conflicted 
preferences. 
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